Position history for Candriam S.C.A.'s holdings in ALNYLAM PHARMACEUTICALS INC
Candriam S.C.A. holds 224,330 shares of ALNY (ALNYLAM PHARMACEUTICALS INC), worth $89.2M as of 2025-Q4. The position was increased (++5.6% shares). ALNY represents 0.4% of Candriam S.C.A.'s portfolio.
Current Value
$89.2M
Current Shares
224,330
Total Value Change
+$3.9M
Total Shares Change
-126,898
Other major holders of ALNY: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 224,330 |
+5.6% |
| $89.2M |
| 0.4% |
| $397.25 |
38 |
| 2025-Q3 | Decreased | 212,416 | -10.8% | $96.9M | 0.5% | $447.49 | 0 |
| 2025-Q2 | Decreased | 238,084 | -4.7% | $77.6M | 0.4% | $322.83 | 0 |
| 2025-Q1 | Decreased | 249,919 | -11.5% | $67.5M | 0.4% | $268.46 | 0 |
| 2024-Q4 | Decreased | 282,407 | -19.7% | $66.5M | 0.4% | $236.01 | 0 |
| 2024-Q3 | Increased | 351,668 | +0.1% | $96.7M | 0.6% | $274.91 | 42 |
| 2024-Q2 | Increased | 351,228 | +10.8% | $85.3M | 0.5% | $243.00 | 47 |